The role of protein kinase C in diabetic microvascular complications

Deng Pan1,2,3, Lin Xu4, Ming Guo1,2

  • 1Xiyuan hospital of China Academy of Chinese Medical Sciences, Beijing, China.

Frontiers in Endocrinology
|September 5, 2022
PubMed

Insights

Protein kinase C (PKC) activation contributes to diabetic microvascular complications by increasing oxidative stress. This review details PKC

Area of Science:

  • Biochemistry and Molecular Biology
  • Endocrinology
  • Cardiovascular Research

Background:

  • Diabetic microvascular complications are a major cause of morbidity.
  • Protein kinase C (PKC) activation is implicated in these complications.
  • High glucose conditions activate PKC, leading to oxidative stress.

Purpose of the Study:

  • To review the role of PKC in diabetic microvascular complications.
  • To present experimental and clinical evidence linking PKC to disease development.

Main Methods:

  • Literature review of experimental studies.
  • Analysis of clinical trial data.
  • Focus on PKC signaling pathways in microvasculature.

Main Results:

  • PKC activation under hyperglycemia stimulates redox reactions and oxidative stress.
  • This leads to microvascular dysfunction, including altered blood flow, permeability, and structural changes.
  • Evidence supports PKC's role in angiogenesis and extracellular matrix accumulation.

Conclusions:

  • PKC is a key mediator in the pathogenesis of diabetic microvascular complications.
  • Targeting PKC may offer therapeutic strategies for managing diabetes-related vascular damage.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
60